Month: February 2021

Kinnevik leder finansieringsrunda i Vivino

Written by Customer Service on February 3, 2021. Posted in Public Companies.

Kinnevik AB (publ) (“Kinnevik”) meddelade idag att bolaget investerar 70 MUSD i den världsledande vinappen Vivino.Vivino är världens största onlinenätverk för vin och den mest nedladdade vinappen. Bolaget har över 50 miljoner användare som vänder sig till plattformen för att få ta del av personliga rekommendationer, objektiva bedömningar av vin och ett urval av vin från fler än 700 partners världen över.Vivino grundades av Heini Zachariassen och Theis Søndergaard som ville skapa en tjänst för människor som vill hitta riktigt bra viner. I likhet med livsmedel är vinmarknaden mycket stor och omsätter runt 400 miljarder USD per år globalt, samtidigt som digitaliseringen släpar efter. Bolaget har nått en betydande skala med över 250 MUSD i bruttoförsäljningsvärde och är lönsamt trots att de i dagsläget endast konverterar cirka 1,5%...

Aura Minerals Approves Development of Almas Gold Project

Written by Customer Service on February 3, 2021. Posted in Public Companies.

ROAD TOWN, British Virgin Islands, Feb. 03, 2021 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA) (“Aura” or the “Company”) is pleased to announce that, based on the conclusion of a completed feasibility study (the “Study”) and detailed analysis by the management team, the Board of Directors of the Company has approved the development of the Almas Gold Project (“Almas” or “the Project”), an open pit gold mine located in the state of Tocantins, Brazil. The Almas Project is expected to be operational by the second half of 2022, with an after-tax total investment estimated at approximately US$73 million, yielding an after-tax net present value (“NPV”) of US$183 million when using the weighted average consensus gold prices for the projected period of US$1,558 per ounce. An upside scenario using a gold price of US$1,800 per ounce yields...

Foresight Solar & Technology VCT plc – Director Resignation

Written by Customer Service on February 3, 2021. Posted in Public Companies.

Foresight Solar & Technology VCT plcDirector ResignationForesight Solar & Technology VCT plc announces that Mr Michael Liston has resigned as a director of the Company with immediate effect from 3 February 2021. Michael has also resigned from the Audit Committee, for which he was formerly Chair.The Board is well advanced with the recruitment of Michael’s replacement and expects to confirm the appointment of an appropriate candidate in due course.Ernie Richardson, Chairman, said ‘we would like to place on record our thanks to Mike for his contribution to the success of the Company since launch and wish him well for the future’.For further information please contact:Gary Fraser, Foresight Group: 020 3667 8181

Brookfield Infrastructure Reports 2020 Year-End Results

Written by Customer Service on February 3, 2021. Posted in Earnings Releases And Operating Results.

BROOKFIELD, NEWS, Feb. 03, 2021 (GLOBE NEWSWIRE) — Brookfield Infrastructure (NYSE: BIP; TSX: BIP.UN) today announced its results for the fourth quarter ended December 31, 2020.“2020 provided a unique backdrop to showcase the resilience and strength of our business,” said Sam Pollock, Chief Executive Officer of Brookfield Infrastructure. “We were also able to invest in high quality assets that were immediately accretive to our results. We are beginning 2021 with a robust liquidity position which will allow us to pursue attractive opportunities and convert them into meaningful investments.”Brookfield reported net income for the year of $394 million ($0.35 per unit) compared to $233 million ($0.06 per unit) in the prior year. Net income for the year benefited from organic growth across our regulated and contracted operations, contributions...

ScottsMiracle-Gro Announces Record First Quarter Results; U.S. Consumer Sales Increase 147%, Hawthorne Sales Rise 71%

Written by Customer Service on February 3, 2021. Posted in Earnings Releases And Operating Results.

Company reports first-ever profit for fiscal first quarterFull year sales guidance increased; Non-GAAP adjusted EPS guidance reaffirmedMARYSVILLE, Ohio, Feb. 03, 2021 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG), one of the world’s leading marketers of branded consumer lawn and garden as well as hydroponic and indoor growing products, today announced company-wide sales increased 105 percent to a record $748.6 million in its fiscal first quarter primarily driven by strong retailer support in the U.S. Consumer segment as well as continued momentum in Hawthorne.For the quarter ended January 2, 2021, income from continuing operations was $0.43 per diluted share, compared with a loss of $1.28 per share in fiscal 2020. Non-GAAP adjusted earnings – which is the basis of the Company’s guidance – was $0.39 per diluted share...

Form 8.3 – [Creightons plc] – Opening Disclosure – (CGWL)

Written by Customer Service on February 3, 2021. Posted in Mergers And Acquisitions.

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should...

Crinetics Pharmaceuticals Advances CRN04777 for Congenital Hyperinsulinism into Phase 1 Study

Written by Customer Service on February 3, 2021. Posted in Public Companies.

SAN DIEGO, Feb. 03, 2021 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced the initiation of a Phase 1 study of CRN04777, an oral, nonpeptide somatostatin receptor type 5 (SST5) agonist being developed as a treatment for congenital hyperinsulinism (HI). Congenital HI is a rare genetic disease associated with dysregulated insulin production in which excess insulin produces life-threatening hypoglycemia (low blood glucose) beginning at birth. The purpose of this study is to evaluate the safety and tolerability of CRN04777 in healthy adult volunteers. In addition, the study is designed to test the mechanism of action of CRN04777...

Brandywine Realty Trust announces Joint Venture with a Global Institutional Investor for its planned 570,000 GSF mixed-use tower at 3025 JFK Blvd within 14-acre, $3.5 billion Schuylkill Yards Neighborhood

Written by Customer Service on February 3, 2021. Posted in Public Companies.

PHILADELPHIA, Feb. 03, 2021 (GLOBE NEWSWIRE) — Brandywine Realty Trust (NYSE:BDN) today announced a partnership with a global institutional investor for its Schuylkill Yards West mixed-use tower at 3025 JFK Blvd. 3025 JFK is planned to be the first vertical development within the 14-acre, $3.5 billion Schuylkill Yards innovation neighborhood Brandywine is master developing in University City, Philadelphia, in partnership with Drexel University. The 570,000 SF project will cost approximately $287 million and will deliver 326 ultra-luxury rental residences, 200,000 SF of Life Science/Innovative Office space, 29,000 SF of indoor/outdoor amenity space and 9,000 SF of retail to the neighborhood. Commencement of construction is planned for March 2021, with an anticipated project completion date of October 2023.“As true believers in the...

Crown Crafts, Inc. to Announce Results for Fiscal 2021 Third Quarter

Written by Customer Service on February 3, 2021. Posted in Public Companies.

GONZALES, La., Feb. 03, 2021 (GLOBE NEWSWIRE) — Crown Crafts, Inc. (the “Company”) (NASDAQ-CM: CRWS) today announced that it intends to release the results of its operations for the third quarter of fiscal year 2021 before the market opens on Wednesday, February 10, 2021. E. Randall Chestnut, Chairman and Chief Executive Officer, and Olivia W. Elliott, President, Chief Operating Officer and Chief Financial Officer, will host a teleconference at 1:00 p.m. Central Standard Time on that day to discuss the Company’s results and answer appropriate questions.Interested individuals may join the teleconference by dialing (844) 861-5504. Please ask to be joined into the Crown Crafts, Inc. call. The teleconference can also be accessed in listen-only mode by visiting the Company’s website at www.crowncrafts.com. The financial information to...

Coya Therapeutics Completes Merger with Nicoya Health Inc. and Announces $10 Million Series A Financing to Advance Pipeline of Regulatory T cell Therapeutics Optimized for Neurodegeneration and Autoimmune Diseases

Written by Customer Service on February 3, 2021. Posted in Mergers And Acquisitions.

-Seminal discoveries in regulatory T-cell (Treg) biology; Novel cryopreservation and manufacturing innovations based on the research of Stanley H. Appel, M.D., internationally renowned researcher and neurologist-HOUSTON, Feb. 03, 2021 (GLOBE NEWSWIRE) — Coya Therapeutics, Inc., (Coya), a clinical-stage biotechnology company developing first-in-class approaches that utilize autologous regulatory T cells (Tregs) and allogeneic exosome therapeutics with a focus on neurodegenerative and autoimmune diseases, today announced that it has concurrently completed a merger with Nicoya Health, Inc. and raised $10 million in Series A financing from institutional and accredited investors. The merger and financing, which include conversion of outstanding debt, was led by Allele Capital Partners LLC. Howard Berman, Ph.D., has been appointed as...

Month: February 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals